Veradigm (NASDAQ:MDRX) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX) in a research note published on Monday. The firm issued a hold rating on the software maker’s stock.

Veradigm Stock Performance

Shares of NASDAQ MDRX opened at $9.24 on Monday. The firm has a 50 day moving average price of $9.63 and a two-hundred day moving average price of $8.96. Veradigm has a 52-week low of $5.01 and a 52-week high of $14.09.

Hedge Funds Weigh In On Veradigm

A number of hedge funds and other institutional investors have recently made changes to their positions in MDRX. Innealta Capital LLC bought a new stake in shares of Veradigm during the 2nd quarter valued at about $38,000. TFO Wealth Partners LLC grew its holdings in Veradigm by 105,280.0% in the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after purchasing an additional 5,264 shares during the period. Meadow Creek Wealth Advisors LLC acquired a new stake in Veradigm in the first quarter worth $83,000. Forest Hill Capital LLC bought a new stake in Veradigm in the fourth quarter valued at $210,000. Finally, Campbell & CO Investment Adviser LLC raised its holdings in shares of Veradigm by 5.7% during the fourth quarter. Campbell & CO Investment Adviser LLC now owns 42,113 shares of the software maker’s stock valued at $442,000 after purchasing an additional 2,263 shares during the period.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.